Show results for
Refine by
Gynecological And Obstetrical Articles & Analysis
24 news found
“Onconova’s upcoming Phase 1/2a trial has been thoughtfully designed to explore narazaciclib’s potential as a best-in-class therapy when combined with letrozole in recurrent LGEEC,” said Bhavana Pothuri, MD, Professor, Department of Obstetrics and Gynecology at NYU Grossman School of Medicine and Director, Gynecologic ...
Gillian has been published in the International Journal of Gynecology and Obstetrics, has presented at the Midwest Biomedical Engineering Career Conference and Appropriate Healthcare Technologies for Developing Countries Seminar in London, and was named Baltimore’s Technologist of the Year. ...
Lila Nachtigall, Professor of Obstetrics and Gynecology at New York University School of Medicine. In the randomized, double-blind, placebo-controlled trial, 32 postmenopausal sexually active women with significant to severe secondary provoked vestibulodynia were enrolled. ...
VirtaMed develops world-class and educationally relevant virtual reality simulators for various medical disciplines such as orthopedics, obstetrics, gynecology, urology and laparoscopy. The VirtaMed LaparoS™ offers an experience that looks and feels real to the users, including correct physical behavior of internal organs and true to life interactions of ...
In addition, the financing will provide the resources to allow KitoTech to introduce its products into a broad spectrum of clinical specialties, including orthopedics, obstetrics and gynecology, and surgery. The financing will also provide support for commercial activities in the consumer market, where there has been rapid sales growth since introducing microMend ...
In 2019, the hospital provided more than 597,650 consultations and admitted nearly 143,530 patients as well as treating 133,112 in the emergency department (this includes adult, cardiology, pediatric, gynecology and obstetrics, ophthalmology and dentistry patients). Each day the hospital’s 9,447 professionals, which includes 884 senior doctors, tackle ...
ByRobocath
(OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, based on its patented biophotonic technology, announced today that enrollment and testing of patients has begun at the Department of Obstetrics & Gynecology Hospital of Fudan University located in Shanghai. ...
Ahead of their attendance at this year’s MEDICA event, AgPlus have appointed a new Chief Scientific Officer, Dr Nic Christofides, who has vast experience of finalising late stage clinical assays to ensure commercial success. Of Cypriot descent, Dr Christofides started his career in 1973 at Hammersmith Hospital, London, as a research assistant where he developed immunoassay for Oestriol ...
Company to showcase first and only FDA-authorized surgical robot that features miniature humanoid-shaped arms and host in-booth surgeons to discuss their experiences with Hominis Tel Aviv, Israel and Fort Lauderdale, FL, November 11, 2021 – Memic Innovative Surgery (Memic), a medical device company dedicated to transforming healthcare with its proprietary surgical robotic technology, ...
The physicians testing LuViva at these institutions represent the leadership of the Chinese obstetrics and gynecology community and include Professor Dr. Wei Lihui of Peking University and Dr. ...
(OTCQB: GTHP), the maker of the LuViva® Advanced Cervical Scan, based on its patented biophotonic technology, announced today it had passed the regulatory compliance review at the Department of Obstetrics & Gynecology Hospital of Fudan University located in Shanghai. ...
Zoltan Hernadi at the Department of Obstetrics and Gynecology at the University of Debrecen, Hungary. As published in the Hungarian medical journal Orvosi Hetilap, Prof. ...
Linus Chuang, MD, a board-certified specialist in Obstetrics and Gynecology and chairman of the department of obstetrics and gynecology at Nuvance Health, who was co-investigator in the study, commented that patients in the study also observed some improvement in menstrual cramping. 75 participants in the study experienced ...
During the rapid demand peak for isolation rooms and effective air decontamination to fight COVID-19, a large amount of hospitals worldwide have learned that the most effective way to decontaminate air is with advanced electric decontamination. Implementing safety measures on all important fronts is crucial for the safety of hospital staff and patients. Increased cleaning, hand hygiene, usage ...
Jeffrey Stringer, professor of obstetrics & gynecology in the UNC School of Medicine and LABOR Study Principal Investigator, stated that “of the nine companies evaluated, MindChild and their fetal research device is the only one that accurately produces the fetal ECG fidelity required for this study to ...
“The initial indication for LACTIN-V is for the prevention of BV recurrence, which tens of millions of women around the world suffer from each year,” said principal investigator and first author Craig R. Cohen, MD, Professor of obstetrics, gynecology & reproductive sciences at the University of California San Francisco. ...
Postpartum hemorrhage is the leading preventable cause of maternal morbidity and mortality3, and obstetrics organizations such as the American College of Obstetrics and Gynecology (ACOG) and the California Maternal Quality Care Collaborative (CMQCC) recommend use of standardized hemorrhage management protocols. ...
Groningen, the Netherlands - 3 February 2017 - ViciniVax, a Dutch biopharmaceutical company in Groningen, announced today the treatment of the first patient with Vvax001 in a Phase I study in patients with a history of cervical intraepithelial neoplasia (CIN) 2 and 3 or cervical cancer. The Phase I study is an investigator-initiated Phase I clinical trial conducted by the Department of Obstetrics ...
Jay Hudgens, assistant professor of obstetrics and gynecology and lead investigator for the UMMC study site. ...
“Being able to present my work at this year’s SAGES Meeting is an honor and privilege,” said Professor Horace Roman, Department of Gynecology and Obstetrics at Rouen University Hospital, France. “I have been sharing my successes with European colleagues and discussing this data in a new forum is exciting. ...